Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Equity/Stock(s)/Options - Dura Biotech; Thubrikar Aortic Valve Inc; Admedus; MicroInterventional Devices; Supira; TriFlo; Adona; Tioga
• Consultant Fee/Honoraria/Speaker's Bureau - Philips; Admedus; TriCares; Dura BioTech
• Grant Support/Research Contract - Edwards Lifesciences; Abbott; Medtronic; Boston Scientific Corporation; JenaValve